GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunflower Pharmaceutical Group Co Ltd (SZSE:002737) » Definitions » E10

Sunflower Pharmaceutical Group Co (SZSE:002737) E10 : ¥1.13 (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Sunflower Pharmaceutical Group Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sunflower Pharmaceutical Group Co's adjusted earnings per share data for the three months ended in Sep. 2024 was ¥0.170. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥1.13 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Sunflower Pharmaceutical Group Co's average E10 Growth Rate was 6.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-03-28), Sunflower Pharmaceutical Group Co's current stock price is ¥18.13. Sunflower Pharmaceutical Group Co's E10 for the quarter that ended in Sep. 2024 was ¥1.13. Sunflower Pharmaceutical Group Co's Shiller PE Ratio of today is 16.04.

During the past 13 years, the highest Shiller PE Ratio of Sunflower Pharmaceutical Group Co was 26.93. The lowest was 15.75. And the median was 21.99.


Sunflower Pharmaceutical Group Co E10 Historical Data

The historical data trend for Sunflower Pharmaceutical Group Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunflower Pharmaceutical Group Co E10 Chart

Sunflower Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 1.14 1.08

Sunflower Pharmaceutical Group Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.06 1.08 1.11 1.12 1.13

Competitive Comparison of Sunflower Pharmaceutical Group Co's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Sunflower Pharmaceutical Group Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunflower Pharmaceutical Group Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sunflower Pharmaceutical Group Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sunflower Pharmaceutical Group Co's Shiller PE Ratio falls into.


;
;

Sunflower Pharmaceutical Group Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sunflower Pharmaceutical Group Co's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.17/115.7848*115.7848
=0.170

Current CPI (Sep. 2024) = 115.7848.

Sunflower Pharmaceutical Group Co Quarterly Data

per share eps CPI Adj_EPS
201412 0.183 99.000 0.214
201503 0.288 99.900 0.334
201506 0.168 99.500 0.195
201509 0.045 100.500 0.052
201512 0.183 100.600 0.211
201603 0.165 102.200 0.187
201606 0.119 101.400 0.136
201609 -0.074 102.400 -0.084
201612 0.310 102.600 0.350
201703 0.168 103.200 0.188
201706 0.160 103.100 0.180
201709 0.186 104.100 0.207
201712 0.305 104.500 0.338
201803 0.251 105.300 0.276
201806 0.233 104.900 0.257
201809 0.107 106.600 0.116
201812 0.369 106.500 0.401
201903 0.280 107.700 0.301
201906 0.240 107.700 0.258
201909 0.117 109.800 0.123
201912 0.329 111.200 0.343
202003 0.270 112.300 0.278
202006 0.140 110.400 0.147
202009 0.137 111.700 0.142
202012 0.450 111.500 0.467
202103 0.390 112.662 0.401
202106 0.140 111.769 0.145
202109 0.160 112.215 0.165
202112 0.520 113.108 0.532
202203 0.380 114.335 0.385
202206 0.310 114.558 0.313
202209 0.180 115.339 0.181
202212 0.600 115.116 0.603
202303 0.700 115.116 0.704
202306 0.390 114.558 0.394
202309 0.370 115.339 0.371
202312 0.450 114.781 0.454
202403 0.440 115.227 0.442
202406 0.390 114.781 0.393
202409 0.170 115.785 0.170

Add all the adjusted EPS together and divide 10 will get our e10.


Sunflower Pharmaceutical Group Co  (SZSE:002737) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Sunflower Pharmaceutical Group Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=18.13/1.13
=16.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Sunflower Pharmaceutical Group Co was 26.93. The lowest was 15.75. And the median was 21.99.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Sunflower Pharmaceutical Group Co E10 Related Terms

Thank you for viewing the detailed overview of Sunflower Pharmaceutical Group Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunflower Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
Welcome Road, 18 East Lake Road, Harbin High-Tech Industrial Development Zone, Harbin, Heilongjiang, CHN
Sunflower Pharmaceutical Group Co Ltd is engaged in pharmaceutical manufacturing, marketing, and scientific research. The company's product profile include Honeysuckle, Weikangling Granules, Autumn pear moisturizing cream, Vitamin AD drops, Pediatric paracetamol granules, Jianweixiaoshi tablets, Pediatric Chai Gui Antipyretic Granules, Pediatric cough syrup, Kang Fu anti-inflammatory suppository, Xiangsha Yangwei Pills, and others.
Executives
Zhou Jian Zhong Executives
Liu Tian Wei Director
Guan Yu Xiu Director
Wu Guo Xiang Executives
Ren Jing Shang Directors, executives
Guan Yan Bin Directors, executives
Wan Yun Guo Executives
Tian Yan Secretary Dong
Tan Chang Executives
Zhang Quan Director
Xu Qing Fen Supervisors
Jiang Feng He Supervisors
Wu Shu Hua Director
Guan Yan Ling Director

Sunflower Pharmaceutical Group Co Headlines

No Headlines